A phase 2 trial of mini‐hyper‐ CVD , blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27463 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Wei-Ying Jen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Pyridazines, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Imidazoles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Takeda Oncology, University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Wei-Ying Jen, Elias Jabbour, Nicholas J Short, Ghayas C Issa, Fadi G Haddad, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Lucia Masarova, Gautam Borthakur, Kelly Chien, Hagop M Kantarjian
Förderung
- NCI NIH HHS
- Takeda Oncology
- University of Texas MD Anderson Cancer Center
- Amgen
Zitieren
APA
Jen, W. Y., Jabbour, E., Short, N. J., Issa, G. C., Haddad, F. G., Jain, N., Pemmaraju, N., Daver, N. G., Masarova, L., Borthakur, G., Chien, K., Garris, R., & Kantarjian, H. M. (2024). A phase 2 trial of mini‐hyper‐ CVD , blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27463
Vancouver
Jen WY, Jabbour E, Short NJ, Issa GC, Haddad FG, Jain N, et al. A phase 2 trial of mini‐hyper‐ CVD , blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American Journal of Hematology. 2024. doi:10.1002/ajh.27463
BibTeX
@article{Jen2024,
author = {Jen, Wei-Ying and Jabbour, Elias and Short, Nicholas J and Issa, Ghayas C and Haddad, Fadi G and Jain, Nitin and Pemmaraju, Naveen and Daver, Naval G and Masarova, Lucia and Borthakur, Gautam and Chien, Kelly and Garris, Rebecca and Kantarjian, Hagop M},
title = {A phase 2 trial of mini‐hyper‐ CVD , blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27463}
}
EUVIMED